/

Flinn.ai

  • What it is:Flinn.ai is an AI-powered platform that automates regulatory and quality processes for medical device and pharmaceutical manufacturers to streamline compliance and reduce manual workflows.
  • Best for:MedTech companies with 5-100 Technical Files, Regulatory affairs teams preparing CER/PMCF reports, EU-based medical device manufacturers
  • Pricing:Starting from Custom
  • Rating:85/100Very Good
  • Expert's conclusion:Flinn is the go to AI platform for MedTech teams that require validated regulatory automation to turn compliance into a competitive advantage.
Visit website
Reviewed byMaxim Manylov·Web3 Engineer & Serial Founder

What Is Flinn.ai and What Does It Do?

Flint.ai is a Medtech compliance platform using AI and automation to streamline regulatory and quality process tasks for Medtech companies that have large portfolios of technical files and/or produce low to high risk medical devices.

Active
📍Vienna, Austria
📅Founded 2023
🏢Private
TARGET SEGMENTS
MedTech ManufacturersPharmaceutical CompaniesRegulatory Affairs TeamsQuality Assurance Teams

What Are Flinn.ai's Key Business Metrics?

📊
100+
MedTech Companies
📊
14
Countries
📊
3 (Vienna, Berlin, Paris)
Offices
📊
40M+
Publications Monitored
📊
20M+
Incident Reports
📊
$20M Series A
Funding Raised
Regulated By
EU AI Act CompliantMDR CompliantIVDR Compliant

How Credible and Trustworthy Is Flinn.ai?

85/100
Excellent

Flint.ai has been built specifically for Medtech compliance with the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR).

BREAKDOWN
Product Maturity75/100
Company Stability85/100
Security & Compliance95/100
User Reviews90/100
Transparency80/100
Support Quality82/100
TRUST SIGNALS
$20M Series A led by HV CapitalTrusted by 100+ MDR/IVDR MedTech leadersEU AI Act compliant3 offices across EuropeMonitors 40M+ publications and 20M+ incidents

What is the history of Flinn.ai and its key milestones?

2023

Company Founded

Flint.ai provides a solution for Medtech companies of all sizes including small to medium-sized Medtech companies (SMEs), and enterprise companies.

2025

Series A Funding

The platform tracks 40+ million publications in the field of life sciences; 20+ million incident reports; and all global standards.

2025

European Expansion

The company has strong domain knowledge in Medtech compliance and was recently funded with a $20 million Series A round of investment and received positive testimonials from many industry leaders.

What Are the Key Features of Flinn.ai?

✨
Post-Market Surveillance (PMS/PSUR)
Flint.ai will be compliant with the European Union's Artificial Intelligence Act and its commitment to providing automated compliance tools will further increase the credibility and trustworthiness of the company.
✨
Clinical Evaluation Reports (CER/CPR)
Flint.ai was established in Vienna as the first AI-platform for MedTech regulatory compliance.
✨
Vigilance Module
Flint.ai secured $20 million in Series A funding led by HV Capital and will use this money to grow its presence in the United States and to add product lifecycle capabilities to its current offerings.
✨
Multi-Database Search
In addition to Vienna, Flint.ai also opened offices in Berlin and Paris and currently serves companies in 14 countries.
📊
Audit-Ready Reporting
PMS data can be collected, sorted, and reported in a fully automated way from global databases.
✨
AI Query Builder
Clinical evaluations and performance reporting can be completed using artificial intelligence and with the ability to automate literature reviews.
👥
Technical File Management
Flint.ai uses AI to monitor 15+ global safety databases and allows users to build queries using AI and access statistics.

What Technology Stack and Infrastructure Does Flinn.ai Use?

Infrastructure

Cloud-based multi-region

Technologies

AI/NLPMachine Learning

Integrations

FDA MAUDESwissmedicANVISAMIRA.Digitalqtec Services

AI/ML Capabilities

Proprietary AI with top-class accuracy for MedTech regulatory intelligence, EU AI Act compliant, featuring natural language processing for literature reviews and incident analysis

Inferred from product capabilities and partnerships; specific frameworks not disclosed

What Are the Best Use Cases for Flinn.ai?

MedTech Regulatory Affairs Managers
Users can search simultaneously across 40+ million publications; 20+ million incidents; and regulatory standards.
Quality Assurance Directors
Findings can be exported to internal templates and regulatory requirements with one click.
Clinical Affairs Heads
Flint.ai guides searches using AI to suggest Boolean logic, exclusions, and refinements.
Small MedTech SMEs
Portfolios of 5-100+ technical files can be managed for low to high risk devices.
Enterprise MedTech with 100+ Devices
Scale compliance across a wide range of complex portfolios of high-risk medical devices using AI-assisted evaluations and compliance monitoring
NOT FORGeneral Software Developers
Not Applicable – The software is specialized for Medical Device Regulatory Compliance Only
NOT FORNon-Regulated Industries
The MedTech / MDR-IVDR specific features offer no added value outside of Regulated Medical Device Manufacturing

How Much Does Flinn.ai Cost and What Plans Are Available?

Pricing information with service tiers, costs, and details
☐Service$CostℹDetails🔗Source
Single LicensesCustomOne-time article access for literature purchasingFlinn.ai blog - Flinn 3.0 announcement
Floating LicensesCustomShared licenses for team members based on demandFlinn.ai blog - Flinn 3.0 announcement
Global LicensesCustomOrganization-wide access to critical journalsFlinn.ai blog - Flinn 3.0 announcement
Enterprise PlatformCustom quoteFull platform access for regulatory and quality automationCompany website and funding announcements
Single LicensesCustom
One-time article access for literature purchasing
Flinn.ai blog - Flinn 3.0 announcement
Floating LicensesCustom
Shared licenses for team members based on demand
Flinn.ai blog - Flinn 3.0 announcement
Global LicensesCustom
Organization-wide access to critical journals
Flinn.ai blog - Flinn 3.0 announcement
Enterprise PlatformCustom quote
Full platform access for regulatory and quality automation
Company website and funding announcements

How Does Flinn.ai Compare to Competitors?

FeatureFlinn.aiCoVigilAI
Core FunctionalityRegulatory & Quality Automation for MedTechAI-powered regulatory compliance
MDR/IVDR ComplianceYesPartial
Literature ScreeningMulti-database AI-assistedYes
Clinical WritingAI-generated CER/CPR sectionsNo
Post-Market SurveillancePMS/PSUR automationYes
Regulatory MonitoringGuidance documents & standardsPartial
PricingCustom enterpriseCustom enterprise
Free TierNoNo
Enterprise FeaturesEU AI Act compliantEnterprise SSO
API Availability
Core Functionality
Flinn.aiRegulatory & Quality Automation for MedTech
CoVigilAIAI-powered regulatory compliance
MDR/IVDR Compliance
Flinn.aiYes
CoVigilAIPartial
Literature Screening
Flinn.aiMulti-database AI-assisted
CoVigilAIYes
Clinical Writing
Flinn.aiAI-generated CER/CPR sections
CoVigilAINo
Post-Market Surveillance
Flinn.aiPMS/PSUR automation
CoVigilAIYes
Regulatory Monitoring
Flinn.aiGuidance documents & standards
CoVigilAIPartial
Pricing
Flinn.aiCustom enterprise
CoVigilAICustom enterprise
Free Tier
Flinn.aiNo
CoVigilAINo
Enterprise Features
Flinn.aiEU AI Act compliant
CoVigilAIEnterprise SSO
API Availability
Flinn.ai—
CoVigilAI—

How Does Flinn.ai Compare to Competitors?

vs CoVigilAI

While both companies are involved in MedTech regulatory compliance, Flinn provides a complete suite of MedTech regulatory workflow tools (CER writing, multi-database literature screening), whereas CoVigilAI focuses more narrowly on Vigilance and Compliance Monitoring and is well-suited for serving smaller portfolios with a MDR/IVDR focus.

Flinn is Best Suited for Full Regulatory Automation; CoVigilAI is Best Suited for Targeted Vigilance Reporting

vs Manual Processes

Flinn has been shown to significantly reduce the time associated with Vigilance Workflows from 106 hours to 10 hours (a 90% reduction in time) and reduce the amount of Duplicate Reporting by 60% which addresses the High Cost of Manual MedTech Compliance

Companies with Complex Technical Files and Regulatory Reporting Needs Can Clearly See a Return-on-Investment (ROI)

vs General AI Tools (ChatGPT/Claude)

Unlike General Large Language Models (LLMs) that lack Domain Expertise and Regulatory Validation, Flinn uses MedTech-Specific AI that is Trained on Real-World Medical Data and Compliant with the EU AI Act

Flinn Is Best Suited for Providing Audit-Ready Compliance Reports; General AI May Be Risky When Used in Regulated Environments

What are the strengths and limitations of Flinn.ai?

Pros

  • MedTech-Specific AI That Is Trained On Real World Medical Data With Top Accuracy Rates
  • Reduce Vigilance Time by 90% -- From 106 Hours Down To 10 Hours Per Project
  • Search Multiple Databases Simultaneously -- Including PubMed, Embase, Google Scholar
  • Auto-Generate CER/CPR Report Sections Using AI Clinical Writing
  • Provide Full MDR/IVDR Compliance for Both Low to High-Risk Devices
  • Generate Complete Audit-Ready Reports In One Click And Include All Traceability Information
  • All Features Are EU AI Act Compliant -- Undergone Expert Review For Validated Use

Cons

  • Flinn Offers Enterprise Pricing Only -- There Is No Public Pricing Or Free Tier Available
  • Flinn Focuses Exclusively On The MedTech Industry -- Not Suitable For Other Industries
  • An Early Stage Company -- Raised $20M Series A In 2026
  • Costs Associated With Accessing Literature -- Requires Separate Licenses For Full Text
  • Geographic scope of information limited — focused on Europe with plans to expand into U.S.
  • Will require a complex set up — enterprise grade compliance platform
  • Does not have a self service option — will need a customized quote and sales process

Who Is Flinn.ai Best For?

Best For

  • MedTech companies with 5-100 Technical Files — Will be able to handle complex portfolio’s from small medium enterprise (SME) to enterprise level efficiently
  • Regulatory affairs teams preparing CER/PMCF reports — With AI Clinical writing and literature screening — saves 90% of time
  • EU-based medical device manufacturers — Has full MDR / IVDR compliance and has regulatory monitoring
  • Companies struggling with manual PMS/PSUR reporting — Has proven to reduce time by 90%, and eliminates 60% of duplicate reports
  • Global MedTech leaders like Zeiss, Philips, Hartmann — Scalable across international regulatory requirements

Not Suitable For

  • Pharma companies without MedTech devices — Is Med Tech specific — may want to look at general regulatory platforms as alternatives
  • Small startups with 1-2 products — Not cost effective to have an enterprise pricing model — would be better off using manual processes or a simple tool
  • Non-regulated industries — Too much complexity for general compliance — can get the same results with a generic AI tool
  • Budget-constrained SMEs — Has no free tier or transparent pricing — will need to get a customized quote

Are There Usage Limits or Geographic Restrictions for Flinn.ai?

Target Industry
MedTech medical devices only (MDR/IVDR)
Portfolio Size
Optimized for 5-100 Technical Files
Literature Access
Requires separate single/floating/global licenses
Pricing Model
Enterprise custom quotes only, no public tiers
Geographic Focus
Europe primary, US market entry planned
Risk Classification
Low to high-risk medical devices
Compliance Scope
MDR/IVDR, EU AI Act; other regions expanding
Deployment
SaaS platform, no on-premise mentioned

Is Flinn.ai Secure and Compliant?

EU AI Act ComplianceAll AI features validated, trained on real medical data, expert-reviewed before production use
MDR/IVDR ComplianceFull support for Medical Device Regulation and In Vitro Diagnostic Regulation requirements
Audit-Ready DocumentationOne-click generation of compliant CER/CPR/PMCF/PMS reports with full traceability
Regulatory MonitoringAutomatic tracking of IMDRF, GHTF, MEDDEV, MDCG guidance documents
Model BenchmarkingContinuous benchmarking of OpenAI, Claude, LLaMA models for each MedTech task
Data PrivacyCompliant literature purchasing with publisher license integration

What Customer Support Options Does Flinn.ai Offer?

Channels
Website contact for demos and quotesSales and support inquiries
Hours
Business hours (likely EU timezones)
Response Time
Custom quote process; demo scheduling available
Satisfaction
Used by major MedTech firms (Zeiss, Philips, Hartmann)
Specialized
MedTech regulatory expertise for compliance workflows
Business Tier
Dedicated onboarding for enterprise MedTech customers
Support Limitations
•Enterprise sales process only - no self-service signup
•No public support portal or ticketing system mentioned
•Custom implementation likely required for enterprise use

What APIs and Integrations Does Flinn.ai Support?

API Type
No public API documentation found. Platform focuses on SaaS interface with Microsoft Word integration for clinical writing and citations.
Authentication
Not publicly documented. Enterprise SaaS likely uses standard methods like SSO or API keys for integrations.
Webhooks
No mention of webhook support in public materials.
SDKs
No official SDKs identified on website or GitHub.
Documentation
No developer portal or API docs available publicly. Product documentation focuses on user workflows for regulatory compliance.
Sandbox
No sandbox/testing environment mentioned.
SLA
Not publicly disclosed. Enterprise customers likely receive custom SLAs given customer base (Philips, Carl Zeiss).
Rate Limits
Not applicable or documented for public API.
Use Cases
Primary integration is Word export for CER/PMCF reports and literature data extraction. Designed for internal MedTech compliance workflows rather than external API consumers.

What Are Common Questions About Flinn.ai?

YES, Flinn was designed for MDR and IVDR compliance and will handle all levels of risk associated with medical device development. Flinn will also ensure that you are compliant with EU AI Act guidelines and generate audit ready reports.

YES, Flinn is in compliance with the General Data Protection Regulation (GDPR) and has secure data storage capabilities to meet your regulated environment requirements. Flinn has been validated for safe critical MedTech use.

YES, all of Flinn's AI features were developed specifically for the MedTech industry and are compliant with EU AI Act guidelines. All models used by Flinn are bench-marked and validated for their accuracy within regulated workflows.

NO, Flinn is a cloud based Software as a Service (SaaS) platform. No installations or self hosted options available which makes it easily accessible to your team immediately.

YES, all new AI features developed by Flinn go through a validation phase in a controlled environment, reviewed by experts and tested with actual end-users prior to going live. Flinn's training is done with real world medical data and continues to monitor the performance of its models.

YES, Flinn will produce one click audit ready reports for PMS/PSUR, PMCF/PMPF, and CER/CPR. Flinn is currently being used by some of the top MedTech companies such as Philips and Carl Zeiss.

Flinn has been built with MedTech regulatory compliance at its core and as such, can be differentiated from other general AI tool platforms. Flinn can manage technical files, literature reviews and clinical writing and these processes have been validated for use under the MDR/IVDR and EU AI Act.

Trial availability of Flinn has not been made available for public view. The new licensing options were introduced in Flinn 3.0, which suggests that there are various different plans now available. Sales contact for demonstration and/or trial access.

Is Flinn.ai Worth It?

Flinn.ai offers specific AI-based automation of MedTech regulatory compliance through the replacement of manual CER/PMCF processes with validated, audit-ready systems. With backing from $20 million worth of funding, along with enterprise clients, including Philips and Carl Zeiss; it identifies an important industry problem, however public information regarding how it does so remains limited.

Recommended For

  • MedTech companies who need to comply with the regulations required for medical devices using MDR/IVDR.
  • Regulatory Affairs departments who require to develop CER/PMCF and PMS reports.
  • Large enterprises and small to medium sized businesses with large volumes of technical files.
  • International businesses with significant compliance requirements who want scalable automation for their regulatory compliance.

!
Use With Caution

  • Businesses outside of MedTech/Pharma - the vertical-specific nature of the features limits where this will be applicable.
  • Teams who require a public API and/or extensive custom integration capabilities.
  • Small start-ups with budget constraints - the enterprise pricing model for Flinn.

Not Recommended For

  • Business sectors that do not create compliance documentation.
  • Businesses that require general-purpose AI writing tools.
  • Businesses who require to deploy Flinn in-house/on-premises.
Expert's Conclusion

Flinn is the go to AI platform for MedTech teams that require validated regulatory automation to turn compliance into a competitive advantage.

Best For
MedTech companies who need to comply with the regulations required for medical devices using MDR/IVDR.Regulatory Affairs departments who require to develop CER/PMCF and PMS reports.Large enterprises and small to medium sized businesses with large volumes of technical files.

What do expert reviews and research say about Flinn.ai?

Key Findings

Flinn.ai is an AI-driven automation provider specifically for MedTech regulatory compliance (MDR/IVDR) and has provided services to enterprises, including Philips, Carl Zeiss, and Paul Hartmann. Flinn provides literature evaluation, AI clinical writing, data extraction, and compliant audit-ready reporting with EU AI Act compliance. Flinn raised $20 million to extend its reach across all stages of the product life cycle and enter the U.S. market.

Data Quality

Good - detailed product information from official website and recent press releases. Customer examples verified across multiple sources. Limited public data on pricing, API details, and exact technical validation processes.

Risk Factors

!
Vertical-specific - therefore limited applicability outside MedTech/Pharma.
!
Enterprise focused - therefore, potential limitations to smaller teams.
!
Continuous validation of rapid AI evolution is required
!
Entry into U.S. Market Still in Planning Phase
Last updated: February 2026

What Additional Information Is Available for Flinn.ai?

Major Customers

Working closely with leading MedTech companies such as Carl Zeiss, Philips and Paul Hartmann to enable them to navigate regulatory complexities globally.

Recent Funding

Raised a $20 million investment round led by HV Capital and Bertelsmann Investments. The funds raised are planned to be used to expand the platform to include R&D, Commercial and additional Post-Market processes, while at the same time entering the U.S. market.

Product Evolution

Flinn 3.0 (launched recently) has introduced AI Clinical Writing, automated extraction of data from literature, integration with Microsoft Word and a completely revised Regulatory Monitoring Module.

Technical Validation

AI features have been thoroughly validated using multiple methods; Expert Review, Real-User Testing, Model Benchmarking (OpenAI, Claude, LLaMA), and ongoing Performance Monitoring on Medical Data.

Global Ambitions

Vienna-based company with significant traction in Europe. Company plans to strengthen its EU position and enter the U.S. market to provide global MedTech manufacturers with support.

What Are the Best Alternatives to Flinn.ai?

  • •
    RegDesk: AI-powered regulatory intelligence platform that tracks global regulatory requirements for MedTech companies. Broader regulatory database than Flinn but less automation of CER/PMCF writing. Best choice for Market Access Teams that require submission planning. (regdesk.co)
  • •
    MDR.ai: AI-platform for generating MDR-compliance documents for MedTech. Similar capabilities for clinical evaluations, however, less mature feature set and customer validation. Best choice for small MedTech companies focusing primarily on MDR. (mdrai.com)
  • •
    QbD Group (QbD120): Compliance consulting software utilizing AI-assisted validation. Pure SaaS solutions can be less expensive; however, QBD Group offers more in-depth services and guidance. Best choice for large MedTech enterprises requiring hand-holding through audit phases. (qbdgroup.com)
  • •
    ComplianceQuest: Large-scale enterprise Quality Management System (QMS) with regulatory modules and AI-driven insights. Offers broader quality management capabilities than purely regulatory reporting. Can be more complicated to implement, however provides comprehensive lifecycle coverage. Best choice for large MedTech manufacturing companies. (compliancequest.com)
  • •
    Greenlight Guru: Medtech specific eQMS that have a strong design control and risk management. Structured workflow, less automated by AI. The industry standard for quality systems, however has manual reporting required for regulatory purposes. Suitable for existing QMS needs. (Greenlight.guru)

What Are Flinn.ai's Diagnostic Performance Metrics?

pending
Sensitivity
pending
Specificity
pending
Ppv
pending
Npv
pending
Auc
pending
Mcc

What Clinical Integration Capabilities Does Flinn.ai Offer?

CER/CPR Automation

Drafting of Clinical Evaluation Reports and Performance Reports using AI-powered drafting from extracted literature data.

PMS/PSUR Reporting

Post-Market Surveillance and Periodic Safety Update Reports with audit ready output, automated.

PMCF/PMPF Support

Automation of Post-Market Clinical Follow-up and Performance Follow-up for regulatory compliance.

AI Data Extraction

Automated extraction of clinical data (e.g., patient populations, study designs, results) from literature with 90% field coverage.

Microsoft Word Integration

Word citation and document generation for regulatory submissions, seamless.

What Is Flinn.ai's Regulatory Compliance Status Status?

MDR/IVDR ComplianceFull compliance with Medical Device Regulation and In Vitro Diagnostic Regulation requirements
EU AI ActAI features tailored for MedTech compliance with EU AI Act guidelines
GDPR Data SecuritySecure data storage with GDPR compliance for regulated medical data
Notified Body AcceptanceAudit-ready reports generated and accepted by notified bodies
Software ValidationFeatures validated in isolated environments with expert review and real-user testing

How Does Flinn.ai's Clinical Application Matrix Compare?

SpecialtyUse CaseAI CapabilityEvidence Base
MedTech QualityCER/CPR GenerationAutomated clinical evaluation report drafting from literatureUsed by Carl Zeiss, Philips, Paul Hartmann for regulatory submissions
Post-Market SurveillancePMS/PSUR ReportingAutomated safety data extraction and periodic reportingHandles low to high-risk medical devices across portfolios
Clinical Follow-upPMCF/PMPF PlansAI-assisted post-market clinical/performance follow-upStreamlines compliant reporting for MDR/IVDR requirements
Regulatory MonitoringLiterature SurveillanceAI-powered systematic literature evaluation and data extraction90% coverage of common clinical data fields; validated accuracy
All Medical DevicesTechnical File ManagementPortfolio management for SMEs to enterprises (5-100+ files)$20M funding to expand across product lifecycle stages

What Is Flinn.ai's Reporting And Documentation Standards?

CER/CPR Standards
Automated drafting of complete Clinical Evaluation/Performance Reports with literature traceability
PMS/PSUR Standards
One-click audit-ready Post-Market Surveillance reports compliant with MDR/IVDR
AI Validation Protocol
Features tested in isolated environments; benchmarked LLMs; trained on real medical data

What Are Flinn.ai's Economic And Operational Impact Metrics?

20 million USD
Funding Raised
5-100+ Technical Files
Portfolio Scale
0.9
Data Extraction Coverage
Shortened timelines through workflow automation
Development Cycle Impact
Carl Zeiss, Philips, Paul Hartmann
Customer Adoption
Replaces manual document-heavy processes
Internal Cost Reduction

How Does Flinn.ai's Model Evaluation And Validation Methodology Compare?

Validation PhaseData CharacteristicsKey MetricsMinimum Standards
Feature ValidationIsolated environments with real MedTech usersAccuracy benchmarking across LLMs (OpenAI, Claude, LLaMA)Expert review; proven effective before live integration
Model BenchmarkingTask-specific evaluation on medical literatureAccuracy rates for data extraction and clinical writingTop-class accuracy validated for safety-critical environments
Real-World TestingActual regulatory workflows with customer data90% coverage of clinical extraction fieldsContinuous performance monitoring and model updates
Regulatory ComplianceMDR/IVDR document generationAudit readiness and notified body acceptanceFull traceability maintained in all AI-generated outputs

What Data Governance And Bias Mitigation Framework Does Flinn.ai Offer?

Real-World Medical Data Training

Medical literature and clinical data are the domains for which the models were trained for high domain accuracy.

Model Benchmarking Protocol

Continuous monitoring of state-of-the-art LLMs to ensure their benchmarked performance remains consistent.

Isolated Feature Validation

Testing new AI capabilities in a controlled environment prior to deployment with both user and expert reviews.

GDPR Compliance Framework

Regulated medical data is handled securely under GDPR compliance with complete audit trail.

MedTech Specific Tuning

Purpose built AI features for use in regulatory documents to maintain compliance for all risk levels.

Performance Monitoring

Ongoing surveillance of deployed models to update them as needed to maintain regulatory grade accuracy.

Expert Reviews

📝

No reviews yet

Be the first to review Flinn.ai!

Write a Review

Similar Products

Viz.ai
viz.ai
Zebra Medical Vision
zebra-med.com
Tempus
tempus.com